1. Companies

  2. Hangzhou Chance Pharmaceuticals

Hangzhou Chance Pharmaceuticals

Hangzhou Chance Pharmaceuticals

A clinical-stage biotechnology company focusing on discovering.
Launch date
Employees
2-10 people
Market cap
-
Enterprise valuation
CAD164—245m (Dealroom.co estimates Oct 2021.)
Hangzhou City Zhejiang (HQ)
https://chancepharmaceuticals.com
https://www.linkedin.com/company/chance-pharmaceuticals/

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD202120222023
Revenues<1m<1m<1m
    • Edit
DateInvestorsAmountRound

CNY10.0m

Angel

CNY55.0m

Series A

CNY80.0m

Series B

$30.0m

Series C
Total FundingCAD68.1m

Related Content

Recent News about Hangzhou Chance Pharmaceuticals

Edit